Carusos Berberine 500

Berberine is the supplement people arrive already sold on, usually from something they read, so the triage our naturopaths run is mostly about what it can't do and who shouldn't take it.

A good fit if

• You're looking at blood sugar and blood lipids together, which is where almost all the trial work sits
• You can take it with meals, two or three times a day, at the doses the trials actually used
• You're comfortable giving it 90 days, because that's the window most of the measured change happened in
• Your prescriber knows you're taking it and has no objection
• You'd rather buy the plain HCl the evidence was built on than pay for an absorption story

Check with us first if

• You take medicine for blood glucose. Berberine adds to the glucose-lowering effect, and your prescriber needs to know.
• You take a statin. The combination trials found larger lipid changes, but berberine-source herbs inhibit the CYP3A4 enzyme that clears several statins.
• You take anything with a narrow safety margin. Goldenseal-type extracts inhibited CYP3A by about 40 per cent over 28 days, which is a pharmacist conversation, not a guess.
• You take metformin. Goldenseal extract cut metformin exposure by about 20 per cent at lower metformin doses, though berberine alone did not.
• You're over 60. The pooled effect was smaller in that group, so expectations should be set accordingly.
• You're already constipated. Constipation was the side effect that came up more often on berberine than on comparators.
• If you take prescription medicines, check with your doctor, pharmacist or our naturopaths before starting.

• Berberine HCl. Best known for: The plain hydrochloride salt, and the form behind essentially every meta-analysed trial. Absorption: The worst of the three. Peak plasma after a 500 mg dose was 0.4 ng/mL in a direct human comparison. Typical use: 500 mg two or three times daily with meals. If a label just says berberine, this is almost certainly what's in it.
• Berberine Phytosome (berberine phospholipid complex). Best known for: Berberine complexed with lecithin, sold at 550 mg a tablet and usually taken twice daily. Absorption: No published head-to-head plasma comparison against the plain salt exists. The absorption advantage is a formulation rationale, not a measured number. Typical use: 1,100 mg a day. It has its own randomised, double-blind, placebo-controlled trial in 49 people with impaired fasting glucose, which is more than dihydroberberine has.
• Dihydroberberine. Best known for: The reduced form, converted back to berberine after absorption, sold at roughly a fifth of the milligram dose. Absorption: The only measured head-to-head: 100 mg reached 3.76 ng/mL against 0.4 ng/mL for 500 mg of HCl, and 6.7 times the two-hour exposure. Typical use: 100 to 200 mg. The trial that measured all that was 5 healthy men over two hours, and it found no difference in glucose or insulin.
• Berberine-bearing botanical extract. Best known for: Berberis aristata, Berberis vulgaris, Oregon grape, Coptis, goldenseal and Phellodendron. The only route into a listed Australian medicine. Absorption: Whole-extract absorption has not been compared with the isolated alkaloid in this evidence set. Typical use: Barberry is positive for lipids across 5 trials and mostly null for glucose across 7. Berberis aristata with silymarin has 4 trials for lipids and null results for liver enzymes.
• Berberine with red yeast rice or with silymarin. Best known for: Combination lipid formulas, and the versions that actually carry the lipid evidence. Absorption: Not separately measured. Typical use: In a 41-trial analysis, combinations outperformed berberine alone. Which on its own did not significantly reduce LDL at all.
• Berberine ursodeoxycholate (HTD1801). Best known for: An ionic salt of berberine and ursodeoxycholic acid, developed as a drug candidate. Absorption: Not comparable. It's a different molecule. Typical use: Trialled at 1,000 mg twice daily in a phase 2 study. It is not a supplement form and its results say nothing about a berberine supplement.

Reference values. There isn't one. Berberine isn't a nutrient. There's no recommended intake, no adequate intake and no deficiency state, and the NHMRC Nutrient Reference Values don't cover it.

Typical supplemental range. Trial doses cluster tightly. Plain berberine HCl was used at 500 mg three times daily (1,500 mg a day) in the foundational trial and in a prediabetes pilot, at 500 mg twice daily in a Hong Kong lipid trial, and at 1,200 to 1,500 mg a day elsewhere. Berberine Phytosome was trialled at 550 mg twice daily, or 1,100 mg a day. Dihydroberberine's only human data used 100 mg and 200 mg, acutely. Anything sold at 400 to 500 mg once a day sits below every meta-analysed dose except in the reduced and phytosome forms.

Upper level. No Australian daily cap exists for any of the eight permitted berberine-bearing botanicals. The only ceiling signal in the evidence runs the other way from the usual sales logic: in a 28-trial analysis of 2,313 people, the effect became unremarkable above 2 g a day, beyond 90 days, and in people over 60. There is no paediatric dose, because there's no paediatric trial.

Worth knowing. Trials dosed it with meals, three times a day, which is also the practical answer for gut tolerance. About one in three people in the original trial had temporary gut symptoms, usually constipation or loose stools. Most of the measured change happened inside 90 days, and the inflammatory-marker signal appeared under five weeks and below 1,000 mg a day. Your needs depend on your age, diet and health circumstances. Talk to one of our naturopaths.

Food first, where the diet allows it.

• Barberry fruit (Berberis vulgaris, dried zereshk), used in Iranian and Middle Eastern cooking: no per-serve berberine figure is available, and the trials used supplemental barberry preparations rather than culinary amounts
• Goldenseal rhizome, Coptis rhizome, Phellodendron bark and Oregon grape root: herbal materials rather than foods; used as extracts, not eaten

This list is the part of the page we will not shorten. If any of it applies to you, talk to one of our naturopaths or your doctor before starting.

• Pregnancy and breastfeeding. Mandatory label warning on Berberis aristata: not recommended for use by pregnant and lactating women.
• Children. No paediatric trial, dose or safety data exists.
• Anyone on a CYP3A4 substrate. Goldenseal-type extracts inhibited CYP3A by around 40 per cent over 28 days.
• Anyone on a CYP2D6 substrate. The same study found roughly 40 per cent inhibition.
• Anyone on metformin. Goldenseal extract reduced metformin exposure about 20 per cent at lower metformin doses.
• Anyone on glucose-lowering medicine. The glucose effect is additive, and the prescriber should know.
• Anyone on a statin cleared by CYP3A4. Route to a pharmacist before combining.
• Constipation and diarrhoea are the common effects; about one in three had transient gut symptoms in the foundational trial.
• Berberine depletes butyrate-producing gut bacteria while enriching gamma-Proteobacteria; the clinical meaning is unknown.
• Goldenseal extract has had possible neurotoxic, hepatotoxic and phototoxic activity suggested in a small number of studies.
• No Australian daily cap exists for any permitted botanical, and the pooled benefit diminished above 2 g a day.
• If you take prescription medicines, check with your doctor, pharmacist or our naturopaths before starting.